Author

Febri Gunawan Sugiokto

University of PittsburghORCID 0009-0004-2097-2744Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Renfeng LiiD· 3 shared Kun ZhangiD· 2 shared Afroditi SotiriouiD· 1 shared Alexandros C. DimopoulosiD· 1 shared Ana BanitoiD· 1 shared Andrew Stewart PoklepoviciD· 1 shared Angeliki M. Stamatouli· 1 shared Anthony C. FaberiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Renfeng LiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Proteomic Screening Identifies HNRNPA2B1 as an Epigenetic Repressor of Epstein-Barr Virus Reactivation

Febri Gunawan Sugiokto, Y Liu, Renfeng Li

This paper identifies HNRNPA2B1 as an epigenetic repressor of Epstein-Barr virus reactivation by facilitating histone demethylase recruitment to viral promoters.

Journal of Virology · Jun 12, 2026Peer-reviewedMicrobiology

EBNA1 SUMOylation by PIAS1 Suppresses EBV Lytic Replication and Enhances Episome Maintenance

Febri Gunawan Sugiokto, Kun Zhang, Yunash Maharjan, Renfeng Li

This study identifies PIAS1-mediated SUMOylation of EBNA1 as critical for suppressing EBV lytic replication and enhancing episome maintenance.

mBio · Dec 11, 2025Peer-reviewedMicrobiology

Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma

Konstantinos V. Floros, Carter K. Fairchild, Jinxiu Li, Kun Zhang, Jane L. Roberts, Richard Kurupi, Durga Paudel, Yanli Xing, Bin Hu, Vita Kraskauskiene, Nayyerehalsadat Hosseini, Shanwei Shen, Melissa M. Inge, Kyllie Smith-Fry, Li Li, , Anthony C. Faber

This study shows that inhibiting SUMOylation with TAK-981 stabilizes cBAF complexes and disrupts the SS18::SSX-driven transcriptome in synovial sarcoma, leading to tumor inhibition.

Nature Communications · Nov 5, 2025Peer-reviewedCancer Biology